Furthermore, statin inhibition of NF-κB activation and signaling reduces transcription of pro-angiogenic genes e.g., VEGFA, decreased tumor growth, increased tumor necrosis and apoptosis [221]. The gene discussed is VEGFA; the disease is neoplasm.